Literature DB >> 35178182

Synthesis of Deuterated Heterocycles with Me2NCD(OMe)2 and Evaluation of the Products for Metabolism by Aldehyde Oxidase.

Chulho Choi1, Anthony A Carlo2, Ciarán N Cronin2, Konghua Jing3, Daniel W Kung1, Jianhua Liu2, Vincent M Lombardo1, Abigail R Turco1, Juxing Yin3, Aijia Yu3, Stephen W Wright1.   

Abstract

The metabolic oxidation of drug-like small molecules by aldehyde oxidase (AO) has commonly been mitigated through the incorporation of deuterium at the oxidation site. We report that dimethylformamide dimethyl acetal and related compounds undergo rapid CH to CD isotopic exchange upon exposure to methanol-d and similar deuterated alcohols. This isotopic exchange process can be used to synthesize Me2NCD(OMe)2 and has significant implications for the use of Me2NCD(OMe)2 in the synthesis of specifically deuterium-labeled compounds. The application of Me2NCD(OMe)2 to the synthesis of various heterocycles that have been associated with AO metabolism is described, and we report the impact of deuteration on the rate of in vitro AO-mediated metabolism.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35178182      PMCID: PMC8842100          DOI: 10.1021/acsmedchemlett.1c00634

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  12 in total

1.  Aldehyde oxidase: an enzyme of emerging importance in drug discovery.

Authors:  David C Pryde; Deepak Dalvie; Qiyue Hu; Peter Jones; R Scott Obach; Thien-Duc Tran
Journal:  J Med Chem       Date:  2010-09-20       Impact factor: 7.446

2.  Systematic structure modifications of imidazo[1,2-a]pyrimidine to reduce metabolism mediated by aldehyde oxidase (AO).

Authors:  Angelica Linton; Ping Kang; Martha Ornelas; Susan Kephart; Qiyue Hu; Mason Pairish; Ying Jiang; Chuangxing Guo
Journal:  J Med Chem       Date:  2011-10-10       Impact factor: 7.446

3.  Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase.

Authors:  B G Lake; S E Ball; J Kao; A B Renwick; R J Price; J A Scatina
Journal:  Xenobiotica       Date:  2002-10       Impact factor: 1.908

4.  A simple method for α-position deuterated carbonyl compounds with pyrrolidine as catalyst.

Authors:  Miao Zhan; Tao Zhang; Haoxi Huang; Yongmei Xie; Yuanwei Chen
Journal:  J Labelled Comp Radiopharm       Date:  2014-07-03       Impact factor: 1.921

Review 5.  Aldehyde oxidase; new approaches to old problems.

Authors:  Christine Beedham
Journal:  Xenobiotica       Date:  2019-06-19       Impact factor: 1.908

6.  Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs.

Authors:  Raman Sharma; Timothy J Strelevitz; Hongying Gao; Alan J Clark; Klaas Schildknegt; R Scott Obach; Sharon L Ripp; Douglas K Spracklin; Larry M Tremaine; Alfin D N Vaz
Journal:  Drug Metab Dispos       Date:  2011-12-21       Impact factor: 3.922

7.  Novel C-C bond cleavage under mild, neutral conditions: conversion of electron-deficient aryl alkyl ketones to aryl carboxylic esters.

Authors:  Nan Zhang; Joseph Vozzolo
Journal:  J Org Chem       Date:  2002-03-08       Impact factor: 4.354

Review 8.  Applications of Deuterium in Medicinal Chemistry.

Authors:  Tracey Pirali; Marta Serafini; Sarah Cargnin; Armando A Genazzani
Journal:  J Med Chem       Date:  2019-01-25       Impact factor: 7.446

9.  Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay.

Authors:  Ciarán N Cronin; JianHua Liu; Nicole Grable; Timothy J Strelevitz; R Scott Obach; Anthony Carlo
Journal:  Protein Expr Purif       Date:  2020-09-07       Impact factor: 1.650

10.  Synthesis and in-vitro anti-proliferative evaluation of some pyrazolo[1,5-a]pyrimidines as novel larotrectinib analogs.

Authors:  Mohamed H Attia; Eman Z Elrazaz; Soad Z El-Emam; Azza T Taher; Hatem A Abdel-Aziz; Khaled A M Abouzid
Journal:  Bioorg Chem       Date:  2019-11-21       Impact factor: 5.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.